First-in-Class Dual Inhibitor of Target 1.1 and Target 1.2 for Neuropathic Pain

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/5m4t-qx73
Cited by: 0

Fields of Study & Subjects

Pain Mechanisms and Treatments Pain Management and Treatment Ion Channels and Receptors

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN